Davis's Drug Guide
dordaviprone
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
dor-da-vip-rone
Trade Name(s)
- Modeyso
Ther. Class.
Pharm. Class.
temporary class
protease activatorsThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Dordaviprone." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580179/all/dordaviprone.
Vallerand AHA, Sanoski CAC. Dordaviprone. Davis's Drug Guide. F.A. Davis Company; 2026. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580179/all/dordaviprone. Accessed August 4, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Dordaviprone. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580179/all/dordaviprone
Vallerand AHA, Sanoski CAC. Dordaviprone [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 August 04]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580179/all/dordaviprone.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - dordaviprone
ID - 3580179
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580179/all/dordaviprone
PB - F.A. Davis Company
ET - 20
DB - Emergency Central
DP - Unbound Medicine
ER -
